Nanopath Inc

New Filing
CIK: 0001940981·Biotechnology·DELAWARE·Filed: Nov 13, 2026
Total Offering

$36,760,740

Amount Sold

$29,891,706

Investors

21

First Sale

Oct 22, 2026

Offering Details

Type
Equity, Debt
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Amogha Tadimety
Related Person
Alison Burklund
Related Person
Jeff Crowe
Related Person
Aaron Sandoski
Related Person

Company

Nanopath Inc

750 MAIN STREET

CAMBRIDGE, MA, 02139

617-249-4542

SEC Filing

0001940981-26-000003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free